Skip to main content
Equibles

BVF INC/IL

Position in ZYME — Zymeworks Inc.

CIK 1056807 San Francisco, CA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$95,388,571
+$1,885,656 QoQ
Shares Held
3,649,142
-2.3% QoQ
Ownership
5.14%
of shares outstanding
% of Portfolio
2.66%
of 13F equity value
Holder Rank
#5
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. ZYME ranks #12 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,965,160 $555,315,164
2 KYMR
Kymera Therapeutics, Inc.
 3,872,052 $444,008,202
3 MLTX
MoonLake Immunotherapeutics
 16,001,284 $311,544,999
4 GHRS
GH Research PLC
 8,650,158 $232,516,247
5 GPCR
Structure Therapeutics Inc.
 3,366,823 $180,697,390
6 NKTR
Nektar Therapeutics
 2,391,075 $166,920,945
7 MIRM
Mirum Pharmaceuticals, Inc.
 1,056,027 $123,629,080
8 XNCR
Xencor Inc
 7,133,720 $114,852,892

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $95,388,571 3,649,142
2026-03-31 $93,502,915 3,734,142
2025-12-31 $103,704,417 3,938,641
2025-09-30 $67,271,988 3,938,641
2025-06-30 $54,077,134 4,308,935
2025-03-31 $51,319,415 4,308,935
2024-12-31 $63,082,808 4,308,935
2024-09-30 $57,829,584 4,607,935
2024-06-30 $49,953,700 5,870,000
2024-03-31 $61,752,400 5,870,000
2023-12-31 $60,989,300 5,870,000
2023-09-30 $37,215,800 5,870,000
2023-06-30 $50,716,800 5,870,000
2023-03-31 $53,064,800 5,870,000
2022-12-31 $46,138,200 5,870,000